CoChat

Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma

Open access
Funamizu, Naotake, Hu, Chaoxin, Lacy, Curtis, Schetter, Aaron, Zhang, Geng, He, Peijun, Gaedcke, Jochen, Ghadimi, Michael B., Ried, Thomas, Yfantis, Harris G., Lee, Dong H., Subleski, Jeffrey, Chan, Tim, Weiss, Jonathan M., Back, Timothy C., Yanaga, Katsuhiko, Hanna, Nader, Alexander, H. Richard, Maitra, Anirban, Hussain, S. Perwez · 2013 · International Journal of Cancer
Cited by 133

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

MIF is a proinflammatory cytokine and is implicated in cancer. A higher MIF level is found in many human cancer and cancer‐prone inflammatory diseases, including chronic pancreatitis and pancreatic cancer. We tested the hypothesis that MIF contributes to pancreatic cancer aggressiveness and predicts disease outcome in resected cases. Consistent with our hypothesis we found that an elevated MIF mRNA expression in tumors was significantly associated with poor outcome in resected cases. Multivariate Cox‐regression analysis further showed that MIF is independently associated with patients' survival (HR = 2.26, 95% CI = 1.17–4.37, p = 0.015). Mechanistic analyses revealed that MIF overexpression decreased E‐cadherin and increased vimentin mRNA and protein levels in pancreatic cancer cell lines, consistent with the features of epithelial‐to‐mesenchymal transition (EMT). Furthermore, MIF‐overexpression significantly increased ZEB1/2 and decreased miR‐200b expression, while shRNA‐mediated inhibition of MIF increased E‐cadherin and miR‐200b expression, and reduced the expression of ZEB1/2 in Panc1 cells. Re‐expression of miR‐200b in MIF overexpressing cells restored the epithelial characteristics, as indicated by an increase in E‐cadherin and decrease in ZEB1/2 and vimentin expression. A reduced sensitivity to the chemotherapeutic drug, gemcitabine, occurred in MIF‐overexpressing cells. Indicative of an increased malignant potential, MIF over‐expressing cells showed significant increase in their invasion ability in vitro, and tumor growth and metastasis in an orthotopic xenograft mouse model. These results support a role of MIF in disease aggressiveness, indicating its potential usefulness as a candidate target for designing improved treatment in pancreatic cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.27736

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Cancer statistics, 2012

    Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679

  • The basics of epithelial-mesenchymal transition

    Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196

  • Pancreatic cancer

    Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570

  • EMT and Dissemination Precede Pancreatic Tumor Formation

    Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · cited 2×

    “Interestingly, pancreatic cancer cells attain invasive properties at an earlier stage of tumor development, which is aided by EMT in an inflammatory microenvironment.(10) These observations underscore the contribution of EMT in pancreatic tumor progression and suggest that inflammation may contribute to the induction…”
    BackgroundSelf-citation
  • Radical causes of cancer

    Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×

    “Increase in the level of cytokines, generation of reactive oxygen and nitrogen species, alteration in miRNA expressions, and induction of NF-kB are some of the major inflammation-mediated events that may contribute to the development and progression of cancer.(8,9) Inflammation enhances tumor progression and cancer ce…”
    BackgroundSelf-citation
  • A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity

    Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649 · cited 1×

    “Many functions of MIF support its potential involvement in tumorigenesis, for example, MIF functions as a negative regulator of p53 and antagonizes p53-mediated growth arrest and apoptosis.(18) It initiates a cascade of events leading to the phosphorylation of ERK1/ERK2, induction of cytoplasmic phospholipase A2, COX2…”
    Background
  • Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients

    Glynn, S. A., Boersma, B. J., Dorsey, T. H., Yi, M., Yfantis, H. G., Ridnour, L. A., Martin, D. N., Switzer, C. H., Hudson, R. S., Wink, D. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42059 · Cited by 254 · cited 1×

    “Immunostaining was evaluated blindly by a board-certified pathologist assigning the intensity and prevalence score as described elsewhere.(19) Briefly, the intensity was assigned a score of 0-3, representing negative, weak, moderate or strong expression, whereas, prevalence was assigned a score of 0-4 representing <10…”
    MethodSelf-citation

Show all 8 references

Cited by

See all 133

Metadata

Authors
Funamizu, N., Hu, C., Lacy, C., Schetter, A., Zhang, G., He, P., Gaedcke, J., Ghadimi, M. B., Ried, T., Yfantis, H. G., Lee, D. H., Subleski, J., Chan, T., Weiss, J. M., Back, T. C., Yanaga, K., Hanna, N., Alexander, H. R., Maitra, A., & Hussain, S. P.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2012-09-14
Volume
132
Issue
4
Pages
785-794
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2029665800
Cited by
133
References
8
FWCI
2.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. https://app.cochat.ai/papers/10.1002/ijc.27736
The paper
Funamizu, N., Hu, C., Lacy, C., Schetter, A., Zhang, G., He, P., Gaedcke, J., Ghadimi, M. B., Ried, T., Yfantis, H. G., Lee, D. H., Subleski, J., Chan, T., Weiss, J. M., Back, T. C., Yanaga, K., Hanna, N., Alexander, H. R., Maitra, A., & Hussain, S. P. (2013). Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. International Journal of Cancer. https://doi.org/10.1002/ijc.27736

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.